Journals / Anadolu Kardiyoloji Dergisi / 2012 / Cilt: 12 - Sayı: 4

Hipertansif hastalarda artmış pentraxin- 3 seviyelerinin kan basıncı seviyeleri ile ilişkisi: Gözlemsel bir çalışma

Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study

Pages
298–304
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Methods: Overall, 80 patients with stage 1 hypertension between 40-61 years of age without any disease and 80 healthy volunteers were included to the study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, relationship between systolic and diastolic blood pressure and pentraxin-3 (PTX3) levels in hypertensive patients was investigated.
📊
Key Findings & Data:Methods: Overall, 80 patients with stage 1 hypertension between 40-61 years of age without any disease and 80 healthy volunteers were included to the study.
💡
Conclusion & Impact:In each group, significant statistical differences were found between PTX3 and CRP levels (PTX3 (ng/mL) 35.25±5.45 and 0.27±0.24, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, relationship between systolic and diastolic blood pressure and pentraxin-3 (PTX3) levels in hypertensive patients was investigated. Methods: Overall, 80 patients with stage 1 hypertension between 40-61 years of age without any disease and 80 healthy volunteers were included to the study. Blood samples obtained to measure PTX3 levels and biochemical analysis. Relationship between PTX3 levels and clinical and biochemical parameters were analyzed using multivariate regression analysis. Results: Although systolic and diastolic blood pressures were significant different, there were no differences regarding age and gender between hypertensives and normotensives. In each group, significant statistical differences were found between PTX3 and CRP levels (PTX3 (ng/mL) 35.25±5.45 and 0.27±0.24, p

Özet

Amaç: Bu çalışmada, hipertansif hastalarda sistolik ve diyastolik kan basınçları ile PTX3 düzeyleri arasındaki ilişki incelendi.Yöntemler: Çalışmaya 40 ile 61 yaş arasında ek hastalığı olmayan evre 1 hipertansiyonlu 80 hasta ile 80 sağlıklı gönüllü dahil edildi. PTX3 düzey tayini ve biyokimyasal analizler için kan örnekleri alındı. Bulgular: Hipertansif ve normotansiflerde sistolik ve diyastolik kan basınçları arasında fark olmasına rağmen cinsiyet ve yaş açısından fark saptanmadı. Her iki grupta PTX3 ve CRP düzeyleri arasında istatistiksel olarak anlamlı fark vardı [Hipertansif ve normotansiflerde sırasıyla PTX3 (ng/mL) 35.25±5.45 ve 0.27±0.24, p

🔖

Cite This Article

SAĞLAM, K., AYDOĞAN, Ü., KUT, A., PARLAK, A., DİKİLİLER, M. A., İYİSOY, A., ÇAKIR, E. (2022). Hipertansif hastalarda artmış pentraxin- 3 seviyelerinin kan basıncı seviyeleri ile ilişkisi: Gözlemsel bir çalışma. Anadolu Kardiyoloji Dergisi, Cilt: 12 - Sayı: 4, 298–304. https://ajindex.com/articles/436664

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cachofeiro V, Miana M, de las Heras N, Martín-Fernández B, Ballesteros S, Balfagón G, et al. Inflammation: a link between hypertension and atherosclerosis. Current Hypertension Reviews 2009
  2. [CrossRef] 2. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, Virdis A, et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation 2002
  3. [CrossRef] 3. Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008
  4. [CrossRef] 4. Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 1994
  5. Lee GW, Goodman AR, Lee TH, Vilcek J. Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins. J Immunol 1994
  6. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007
  7. [CrossRef] 7. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med 2010
  8. [CrossRef] 8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003
  9. [CrossRef] 9. Fazzini F, Peri G, Doni A, Dell’Antonio G, Dal Cin E, Bozzolo E, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sides of inflammation. Arthritis Rheum 2001
  10. [CrossRef] 10. Tong M, Carrero JJ, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2007
  11. [CrossRef] 11. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005
  12. [CrossRef] 12. Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, et al. PTX3, A prototypical long pentraxin, is an early